Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Impact of Race, Socioeconomic Status, and Clinicopathologic Features on Clinical Outcomes in Triple-Negative Breast Cancer in the ECOG-ACRIN EA1131 Trial.
Journal: JCO oncology advances
Published: May 18, 2026
Clinicopathologic characteristics of early-onset breast cancer among unselected young Black women.
Journal: Cancer
Published: February 13, 2026
Timing of BRCA Genetic Testing and Surgical Decision-Making Among Young Black Women With Breast Cancer.
Journal: Cancer control : journal of the Moffitt Cancer Center
Published: December 08, 2025
Efficacy and Genomic Analysis of HER2-Mutant Metastatic Triple-Negative Breast Cancer Treated with Neratinib Alone or with Trastuzumab in the SUMMIT Basket Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 13, 2025
Identification of racial disparities across MammaPrint and BluePrint subtypes in HR + HER2- breast cancer.
Journal: NPJ breast cancer
Published: September 09, 2025
Multi-Ancestry Transcriptome-wide Association Studies Uncover New Insights into Breast Cancer Genetics and Biology.
Journal: medRxiv : the preprint server for health sciences
Published: August 20, 2025
Landscape of somatic genetic alterations and PAM50 intrinsic subtypes in breast cancer associated with germline pathogenic variants in DNA-repair genes.
Journal: Journal of the National Cancer Institute
Published: August 19, 2025
Obesity's Disparate Impact on COVID-19 Outcomes in Asian American Patients with Cancer.
Journal: medRxiv : the preprint server for health sciences
Published: June 04, 2025
Circulating Tumor Cell Dynamics after CDK4/6 Inhibitor for Hormone Receptor-Positive Metastatic Breast Cancer: A Biomarker Analysis from the PACE Phase II Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 19, 2025
Improved polygenic risk prediction models for breast cancer subtypes in women of African ancestry.
Journal: Nature genetics
Published: February 15, 2025
Circulating tumor DNA mutational landscape and dynamics after progression on a CDK4/6 inhibitor in the PACE phase II trial for metastatic HR-positive/HER2-negative breast cancer.
Journal: ESMO open
Published: December 19, 2024
Last Updated: 09/26/2026